AccentHealth expands menu of waiting room programming

Share this article:
AccentHealth is launching nine condition-specific TV networks that it says will reach 13 million patients monthly in waiting rooms.

The company is launching networks focused on: diabetes; heart health; men's health; mental health; women's health; rheumatology; allergies; asthma; and GERD. The networks will join the company's four existing channels (The Diabetes Network, Silver Network, Ob/Gyn Network and Pediatric Network) featuring programming produced by CNN's medical unit and co-hosted by Dr. Sanjay Gupta and Robin Meade, along with EveryDay Health experts.

“The digital age allows us to refine health messaging,” said AccentHealth CEO Daniel Stone, “directing specific information to only the most relevant patients, providing the information they want, when and where they are eager to learn and can discuss it with their physicians.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...